TScan Therapeutics
TCRX
TCRX
26 hedge funds and large institutions have $29M invested in TScan Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% less capital invested
Capital invested by funds: $30.4M → $29M (-$1.45M)
1.03% less ownership
Funds ownership: 51.26% → 50.23% (-1%)
Holders
26
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$203K | |
| 2 | +$95.6K | |
| 3 | +$48K | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$34K |
| 5 |
CC
Cannell Capital
Alta,
Wyoming
|
+$33.8K |
Top Sellers
| 1 | -$579K | |
| 2 | -$200K | |
| 3 | -$148K | |
| 4 |
Jane Street
New York
|
-$32K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8.89K |